Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
4.445
+0.035 (0.79%)
Nov 21, 2024, 2:40 PM EST - Market open

Humacyte Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-152.87-110.78-11.97-26.48-66.52-85.42
Depreciation & Amortization
7.227.728.218.248.356.75
Other Amortization
-0.481.550.98--
Loss (Gain) From Sale of Assets
0.010.020.01-0.180.07
Stock-Based Compensation
5.856.836.1810.154.694.46
Other Operating Activities
43.2515.85-76.14-73.520.10.06
Change in Accounts Receivable
-0.030.15-0.060.49-0.19
Change in Accounts Payable
3.994.81-0.51-0.2-0.892.43
Change in Unearned Revenue
------0.59
Change in Other Net Operating Assets
1.951.731.39-0.3-1.970.64
Operating Cash Flow
-90.6-73.31-71.13-81.19-55.57-71.79
Capital Expenditures
-1.66-2.28-1.05-0.22-0.32-8.13
Sale of Property, Plant & Equipment
----0.05-
Investment in Securities
-2.115.89-8--
Investing Cash Flow
-1.66-0.174.85-8.22-0.27-8.13
Long-Term Debt Issued
---29.663.25-
Long-Term Debt Repaid
--34.07-1.98-1.73-1.5-1.29
Net Debt Issued (Repaid)
-2.49-34.07-1.9827.931.75-1.29
Issuance of Common Stock
44.930.570.542430.31.22
Other Financing Activities
20.438.01--3.95--
Financing Cash Flow
62.844.51-1.45266.982.05-0.07
Net Cash Flow
-29.42-68.97-67.73177.57-53.78-79.99
Free Cash Flow
-92.26-75.59-72.18-81.41-55.89-79.91
Free Cash Flow Margin
---4611.95%-6445.76%-3748.22%-1291.61%
Free Cash Flow Per Share
-0.82-0.73-0.70-2.04-9.69-3.97
Cash Interest Paid
-1.612.671.12--
Levered Free Cash Flow
-58.33-45.34-40.66-34.63-31.56-
Unlevered Free Cash Flow
-53.02-41.69-38.33-32.89-30.19-
Change in Net Working Capital
-5.88-6.63-1.190.312.54-
Source: S&P Capital IQ. Standard template. Financial Sources.